Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 1263774-59-9, Jte-052, Jte-052a, Corectim, Leo 124249a, Leo 124249
Molecular Formula
C16H18N6O
Molecular Weight
310.35  g/mol
InChI Key
LOWWYYZBZNSPDT-ZBEGNZNMSA-N
FDA UNII
9L0Q8KK220

Delgocitinib is under investigation in clinical trial NCT03683719 (Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 Mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema).
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile
2.1.2 InChI
InChI=1S/C16H18N6O/c1-11-8-22(13(23)2-5-17)16(11)4-7-21(9-16)15-12-3-6-18-14(12)19-10-20-15/h3,6,10-11H,2,4,7-9H2,1H3,(H,18,19,20)/t11-,16-/m0/s1
2.1.3 InChI Key
LOWWYYZBZNSPDT-ZBEGNZNMSA-N
2.1.4 Canonical SMILES
CC1CN(C12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N
2.1.5 Isomeric SMILES
C[C@H]1CN([C@]12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N
2.2 Other Identifiers
2.2.1 UNII
9L0Q8KK220
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1,6-diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3s,4r)-

2. 3-((3s,4r)-3-methyl-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1,6-diazaspiro(3.4)octan-1-yl)-3-oxopropanenitrile

3. Jte-052

2.3.2 Depositor-Supplied Synonyms

1. 1263774-59-9

2. Jte-052

3. Jte-052a

4. Corectim

5. Leo 124249a

6. Leo 124249

7. Leo-124249a

8. Leo-124249

9. Delgocitinib [usan]

10. 9l0q8kk220

11. 3-[(3s,4r)-3-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile

12. 3-((3s,4r)-3-methyl-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1,6-diazaspiro(3.4)octan-1-yl)-3-oxopropanenitrile

13. 3-[(3s,4r)-3-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile

14. Delgocitinibum

15. Corectim (tn)

16. 3-((3s,4r)-3-methyl-6-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile

17. 3-[(3s,4r)-3-methyl-6-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile

18. Ent-60

19. Delgocitinib (jan/usan)

20. Delgocitinib [inn]

21. Delgocitinib [jan]

22. Delgocitinib [who-dd]

23. Unii-9l0q8kk220

24. Gtpl9619

25. Jte052

26. Chembl4297507

27. Schembl12547007

28. Chebi:167600

29. Dtxsid401336933

30. Ex-a5577

31. Bdbm50545650

32. At24880

33. Leo-124249;jte-052

34. Bd178539

35. Hy-109053

36. Cs-0031558

37. D11046

38. A936874

39. 1,6-diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-.beta.-oxo-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3s,4r)-

40. 1,6-diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3s,4r)-

41. Fhx

2.4 Create Date
2011-03-14
3 Chemical and Physical Properties
Molecular Weight 310.35 g/mol
Molecular Formula C16H18N6O
XLogP31.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass310.15420922 g/mol
Monoisotopic Mass310.15420922 g/mol
Topological Polar Surface Area88.9 Ų
Heavy Atom Count23
Formal Charge0
Complexity544
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of dermatitis and eczema